HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the metabolic effects of GIP receptor antagonism and PYY(3-36) receptor activation in high fat fed mice.

Abstract
Glucose-dependent insulinotropic polypeptide (GIP) and peptide YY (PYY) are secreted from the intestinal K- and L-cells, respectively, following a meal. Both peptides are believed to play a key role in glucose homeostasis and energy expenditure. This study investigated the effects of daily administration of the stable and specific GIP-R antagonist, (Pro(3))GIP (25 nmol/kg) and the endogenous truncated form of PYY, PYY(3-36) (50 nmol/kg), in mice fed with a high fat diet. Daily i.p. injection of (Pro(3))GIP, PYY(3-36) or combined peptide administration over 24 days significantly (P<0.05-0.01) decreased body weight compared with saline-treated controls without change in food intake. Plasma glucose levels and glucose tolerance were significantly (P<0.05) lowered by (Pro(3))GIP treatment alone, and in combination with PYY(3-36). These changes were accompanied by a slight improvement of insulin sensitivity in all of the treatment groups. (Pro(3))GIP treatment significantly reduced plasma corticosterone (P<0.05), while combined administration with PYY(3-36) significantly lowered serum glucagon (P<0.05). No appreciable changes were observed in either circulating or glucose-stimulated insulin secretion in all treatment groups. (Pro(3))GIP-treated mice had significantly (P<0.01) lowered fasting glucose levels and an improved (P<0.05) glycemic response to feeding. These comparative data indicate that chemical ablation of GIP receptor action using (Pro(3))GIP provides an especially effective means of countering obesity and related abnormalities induced by consumption of high fat energy rich diet.
AuthorsN Irwin, K Hunter, P R Flatt
JournalPeptides (Peptides) Vol. 28 Issue 11 Pg. 2192-8 (Nov 2007) ISSN: 0196-9781 [Print] United States
PMID17884253 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Dietary Fats
  • Insulin
  • Peptide Fragments
  • Receptors, Gastrointestinal Hormone
  • peptide YY receptor
  • Peptide YY
  • peptide YY (3-36)
  • Gastric Inhibitory Polypeptide
  • Glucagon
  • gastric inhibitory polypeptide receptor
  • Corticosterone
Topics
  • Animals
  • Blood Glucose (metabolism)
  • Corticosterone (blood)
  • Dietary Fats (administration & dosage)
  • Gastric Inhibitory Polypeptide (administration & dosage, pharmacology)
  • Glucagon (blood)
  • Glucose Tolerance Test
  • Insulin (blood)
  • Male
  • Mice
  • Obesity (blood, etiology)
  • Peptide Fragments
  • Peptide YY (administration & dosage, pharmacology)
  • Receptors, Gastrointestinal Hormone (agonists, antagonists & inhibitors, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: